The SGC catalyzes research in new areas of human biology and drug discovery by focusing explicitly on less well-studied areas of the human genome. The SGC accelerates research in these new areas by making all its research output available to the scientific community with no strings attached, and by creating an open collaborative network of scientists in hundreds of universities around the world and in eight global pharmaceutical companies.

Research

Structural Genomics Consortium

Aled Edwards

Max Morgan

Cheryl Arrowsmith

Michael Sundström

Timothy Willson

Stefan Knapp

Susan McCormick

The current leadership team at Structural Genomics Consortium has a wealth of experience in both academia and industry. Prior to joining SGC, members of the team held positions at various universities, including McGill University and the University of Oxford, as well as at companies such as M4K Pharma. This experience gives the team a unique perspective on the challenges and opportunities facing SGC.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Structural Genomics Consortium

Board of Directors

CEO and Executive Team